Julie Ross
-
- Acute Myeloid Leukemia Research 3
-
- Hemoglobinopathies and Related Disorders 2
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 3
- Genomics and Chromatin Dynamics 3
- Cancer-related gene regulation 2
-
- T-cell and B-cell Immunology 2
- Co-authors
- Éric MilotEl Bachir AffarStefania BottardiElliot DrobetskyIan Hammond-MartelNazar MashtalirFrank J. RauscherSalima Daou
- Cited by
- HematologyGeneticsMolecular Biology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (2 papers)The EMBO Journal (1 paper)
- Partner nations
- CanadaGermanyUnited States
In The Last Decade
Julie Ross
14 papers receiving 492 citations
Peers
Comparison fields: 5 of 51
- Hematology 67
- Genetics 63
- Molecular Biology 373
- Cancer Research 51
- Oncology 86
Countries citing papers authored by Julie Ross
This map shows the geographic impact of Julie Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Ross more than expected).
Fields of papers citing papers by Julie Ross
This network shows the impact of papers produced by Julie Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Ross. The network helps show where Julie Ross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2022 | 7 | |
| 3 | 2020 | 22 | |
| 4 | 2020 | 9 | |
| 5 | 2019 | 18 | |
| 6 | 2018 | 15 | |
| 7 | The transcription factor Miz-1 is required for embryonic and stress-induced erythropoiesis but dispensable for adult erythropoiesis. | 2014 | 2 |
| 8 | 2014 | 30 | |
| 9 | 2012 | 50 | |
| 10 | 2011 | 27 | |
| 11 | 2010 | 205 | |
| 12 | 2009 | 10 | |
| 13 | 2008 | 56 | |
| 14 | 2006 | 38 |
About Julie Ross
Julie Ross is a scholar working on Genetics, Hematology and Molecular Biology, having authored 14 papers that have together received 497 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Acute Myeloid Leukemia Research (3 papers), Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (3 papers), Genomics and Chromatin Dynamics (3 papers), Hemoglobinopathies and Related Disorders (2 papers), Cancer-related gene regulation (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hematology (67 citations), Genetics (63 citations) and Molecular Biology (373 citations). Julie Ross has collaborated with scholars based in Canada, Germany and United States. Frequent co-authors include Éric Milot, El Bachir Affar, Stefania Bottardi, Elliot Drobetsky, Ian Hammond-Martel, Nazar Mashtalir, Frank J. Rauscher, Salima Daou, Helen Yu and Yang Shi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.